Trinity Health Of New England’s Thoracic Oncology program is a multidisciplinary team of specialists committed to providing individualized care for patients with lung cancer, mesothelioma, and other ...

Mr. A, a 76-year-old elderly patient diagnosed with right upper lobe lung cancer. Prior to A's surgery, the medical team ...

Health experts have slammed “brutal” underfunding of lung cancer research as the disease kills 9000 Australians yearly – more ...

The Mid-South health system identified over twice as many incidental pulmonary nodules, half of which were in a higher-risk ...

Dr. Choucair holds memberships in numerous professional societies and associations, including the American College of Physicians, the American Society of Clinical Oncology, the Michigan Society of ...

Among persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

Continuing the hospital’s dedication and work in lung cancer and pulmonology, Ellis Medicine opened the Nan and Hugh Murphy ...

Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...

JJ Watt confirmed that his brother TJ Watt had a successful surgery after suffering a collapsed lung at the Pittsburgh ...

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

Learn about the clinical trials and research at MSK that led to 11 FDA approvals in 2025, expanding treatment options for a range of different cancers.